CPH
ALPN

C Partners Holding’s Alpine Immune Sciences Inc ALPN Stock Holding History

C Partners Holding’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,500
Closed -$394K – 36
2015
Q2 		$394K Buy
+6,500
New +$387K 0.18% 42

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

C Partners Holding's ALPN Position: Q3 2015 in Review

C Partners Holding sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2015, closing a stake of 6,500 shares — an estimated $394K sold.

C Partners Holding first reported a position in ALPN in Q2 2015 and held it in 1 quarter. The position peaked at $394K in Q2 2015. 63 funds tracked by Wall St. Rank hold ALPN as of Q3 2015.

  • C Partners Holding reported no remaining Alpine Immune Sciences Inc position as of Q3 2015 after selling out during the quarter.
  • C Partners Holding sold 6,500 Alpine Immune Sciences Inc shares in Q3 2015, an estimated $394K.
  • C Partners Holding first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 1 quarter.
  • C Partners Holding's Alpine Immune Sciences Inc position peaked at $394K in Q2 2015.
  • 63 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2015.

Based on C Partners Holding's 13F filing for Q3 2015, filed 12 Nov 2015.